David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.52B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.43B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$798M |
| 4 |
Amazon
AMZN
|
+$646M |
| 5 |
Texas Instruments
TXN
|
+$619M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.31B |
| 2 |
Broadcom
AVGO
|
+$1.01B |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$863M |
| 4 |
Western Digital
WDC
|
+$595M |
| 5 |
Meta Platforms (Facebook)
META
|
+$591M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.6% |
| 2 | Consumer Discretionary | 9.12% |
| 3 | Healthcare | 7.62% |
| 4 | Industrials | 7.14% |
| 5 | Financials | 6.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
CoreCivic
CXW
$3.36B
| $1.4M | ﹤0.01% |
73,403
+40,457
| +123% | +$741K |
|
3202
Duke Energy
DUK
$95B
| $1.4M | ﹤0.01% |
11,965
-30,363
| -72% | -$3.71M |
|
3203
eHealth
EHTH
$38.1M
| $1.4M | ﹤0.01% |
304,632
-291,946
| -49% | -$1.29M |
|
3204
CALL
Bath & Body Works
BBWI
$3.81B
| $1.4M | ﹤0.01% |
+69,700
| New | +$1.54M |
|
|
MAZE
3205
Maze Therapeutics
MAZE
$1.64B
| $1.4M | ﹤0.01% |
+33,694
| New | +$1.16M |
|
3206
Virgin Galactic
SPCE
$438M
| $1.39M | ﹤0.01% |
434,503
-238,615
| -35% | -$899K |
|
3207
PUT
Ingersoll Rand
IR
$31B
| $1.39M | ﹤0.01% |
17,600
| – | – |
|
3208
PUT
PENN Entertainment
PENN
$2.39B
| $1.39M | ﹤0.01% |
+94,400
| New | +$1.47M |
|
3209
CALL
Quantum Computing Inc
QUBT
$1.89B
| $1.39M | ﹤0.01% |
+135,600
| New | +$1.93M |
|
3210
CALL
Inhibrx
INBX
$1.84B
| $1.39M | ﹤0.01% |
+17,600
| New | +$1.2M |
|
3211
Accuray
ARAY
$31.6M
| $1.39M | ﹤0.01% |
1,683,269
-110,122
| -6% | -$137K |
|
|
AVDL
3212
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
| $1.39M | ﹤0.01% |
64,300
+21,400
| +50% | +$415K |
|
3213
OptimizeRx
OPRX
$146M
| $1.38M | ﹤0.01% |
112,867
-208,184
| -65% | -$3.4M |
|
3214
Xenon Pharmaceuticals
XENE
$6.18B
| $1.38M | ﹤0.01% |
30,851
-17,604
| -36% | -$739K |
|
3215
Runway Growth Finance
RWAY
$274M
| $1.38M | ﹤0.01% |
154,708
+26,455
| +21% | +$251K |
|
3216
COPT Defense Properties
CDP
$4.23B
| $1.38M | ﹤0.01% |
49,479
-19,251
| -28% | -$555K |
|
3217
Mitek Systems
MITK
$801M
| $1.38M | ﹤0.01% |
130,342
+16,480
| +14% | +$156K |
|
3218
MidCap Financial Investment
MFIC
$794M
| $1.37M | ﹤0.01% |
119,977
+104,988
| +700% | +$1.25M |
|
3219
Lindsay Corp
LNN
$1.16B
| $1.37M | ﹤0.01% |
11,623
| – | – |
|
3220
Revolution Medicines Inc Warrant
RVMDW
$134M
| $1.37M | ﹤0.01% |
1,454,895
| – | – |
|
3221
CALL
C.H. Robinson
CHRW
$17.7B
| $1.37M | ﹤0.01% |
8,500
+5,800
| +215% | +$857K |
|
3222
AppFolio
APPF
$7.9B
| $1.37M | ﹤0.01% |
5,873
-2,389
| -29% | -$568K |
|
|
BLFY
3223
DELISTED
Blue Foundry Bancorp
BLFY
| $1.37M | ﹤0.01% |
109,824
+45,385
| +70% | +$453K |
|
3224
PUT
TripAdvisor
TRIP
$1.16B
| $1.36M | ﹤0.01% |
93,400
+51,700
| +124% | +$787K |
|
3225
Fabrinet
FN
$15.7B
| $1.36M | ﹤0.01% |
2,986
-3,027
| -50% | -$1.32M |
|
Similar funds
David Shaw's Q4 2025 Portfolio in Review
As of Q4 2025, David Shaw held 5,141 positions worth $182B, up 3% from $177B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2025 filing shows 639 new, 1,734 increased, 1,574 reduced and 583 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 1,175,000 shares worth $805M. The largest sale was Micron Technology, an estimated $1.31B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2025 buy was iShares Core S&P 500 ETF: 1,175,000 shares worth $805M.
- David Shaw added most to Advanced Micro Devices in Q4 2025, an estimated $1.52B increase.
- David Shaw's biggest Q4 2025 reduction was Micron Technology, cutting an estimated $1.31B.
- David Shaw fully exited Vanguard Short-Term Corporate Bond ETF in Q4 2025, selling an estimated $499M.
- David Shaw's ten largest holdings make up 12% of its $182B portfolio in Q4 2025.
- David Shaw opened 639 new positions and closed 583 in Q4 2025.
- David Shaw's portfolio value rose 3% quarter-over-quarter to $182B.
Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.